Enterprise League logo

Product

Bach1 Inhibitors

BIOTECHNOLOGY

byIMMvention Therapeutix, Inc.

United States (US)

ABOUT THE PRODUCT

Development of orally available small molecule inhibitors targeting Bach1, a key transcription factor involved in various disease pathways.

Information is owner-confirmed

Last updated 5 months ago

Price range
N/A

Other products/services from IMMvention Therapeutix, Inc.

Default Product Image
fetal hemoglobin induction therapies
Biotechnology

N/A

IMMvention Therapeutix, Inc. Logo

IMMvention Therapeutix, Inc.

United States (US)